In the BioHarmony Drug Report Database
Argatroban (argatroban) is a small molecule pharmaceutical. Argatroban was first approved as Argatroban on 2000-06-30. It is used to treat thrombocytopenia and thromboembolism in the USA. The pharmaceutical is active against prothrombin. Argatroban’s patent is valid until 2027-09-26 (FDA).
Image (chem structure or protein)